Market Rotations Create Buying Opportunities, Says Jim Cramer

On Monday, CNBC’s Jim Cramer reassured investors regarding the recent market fluctuations. He argued that the selling from institutional investors has opened doors for buying some undervalued blue-chip stocks.

“By tracking the rotation and understanding the emerging themes, you can spot some really undervalued stocks,” Cramer mentioned during his “Mad Money” segment.

This commentary followed last week’s June jobs report, which revealed a hiring slowdown. Cramer pointed out that this has led some asset managers to rethink their portfolio strategies. He noted that institutional investors often trade groups of stocks linked to specific economic themes, causing significant dips in blue-chip companies despite no actual changes in their fundamentals.

“These rotations can be unpredictable and often create amazing chances to acquire high-quality companies at lower prices,” he stated, adding, “Many of these opportunities emerged today.”

Cramer highlighted PepsiCo, noting that the recent dip has largely undone gains from the previous quarter’s strong earnings report, presenting a good entry point ahead of the company’s earnings call on July 9.

He made similar observations about Starbucks, indicating that the latest downturn provides a chance for investors to buy in as CEO Brian Niccol continues to implement changes to improve the company. The Charitable Trust, managed by Cramer, holds shares in Starbucks.

For those looking to embrace more risk, he encouraged interest in Constellation Brands, arguing that the latest financial results indicate potential stabilization in the beer sector, despite ongoing concerns regarding spirits.

“I can’t think of a better time to be a buyer,” he said, also mentioning TJX Companies as a favorable choice. He explained that when consumers tighten their budgets, off-price retailers often benefit, and excess inventory at traditional retailers gives TJX an edge in offering discounted items.

Aside from consumer stocks, another notable trend on Monday was the rise in artificial intelligence stocks, taking a toll on outperforming health care stocks, including Johnson & Johnson. Cramer characterized the company as now being a “pure pharmaceutical company” following its spinoff, indicating that the business is likely to become more appealing ahead of its earnings report on July 15.

“Stocks like J&J, PepsiCo, Starbucks, Constellation Brands, and TJX all saw declines today,” Cramer remarked. “I think this is an excellent opportunity to buy as they were all collateral damage from this sector rotation sell-off.”